Today's updates and additions to the Biotechnology Events database can be found at the top. We will be making updates available throughout the day. Past entries are listed below.
.
Updates for May 23, 2013
1) Celgene - Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE® sNDA in Advanced Pancreatic Cancer
European Medicines Agency Accepts Regulatory Submission of Type II Variation for ABRAXANE for the Treatment of Advanced Pancreatic Cancer
http://www.biotechnologyevents.com/node/6914
.
Updates for May 22, 2013.
Updated Regulatory Watch List as of: 5/23/13.
The following is a list of companies with near term regulatory events pending:
US Approval
FDA PDUFA Date (FDA Decision date)
.
Genzme/Sanofi - April 11, 2013
Lemtrada - http://www.biotechnologyevents.com/node/5465
Allergan (MAP Pharmaceuticals) - April 15, 2013
Levadex - http://www.biotechnologyevents.com/node/5497 (Complete response letter)
Sucampo/Takeda - April 26, 2013
Lubiprostone (Amitiza) - http://www.biotechnologyevents.com/node/5707 (Approved)
Gilead Sciences, Inc. - April 27, 2013
Updated Clinical Data Watch List as of: 5/23/13.
.
The following is a list of companies with near term (within one year) phase III clinical data read-outs pending:
.
Acadia Pharmaceuticals, Inc. (ACAD)
Pimavanserin 020 - http://www.biotechnologyevents.com/node/3027 (COMPLETED)
.
Alkermes, Inc. (ALKS)
ALKS-37 - http://www.biotechnologyevents.com/node/4193 (COMPLETED)
.
Amgen, Inc. (AMGN)
OncoVEX GM-CSF - http://www.biotechnologyevents.com/node/3673
.
Amicus Therapeutics, Inc. (FOLD)
AT2220 - http://www.biotechnologyevents.com/node/1310 (COMPLETED)
Disclaimer: Trading Securities is Risky. A trader is subject to this risk and can lose money. Please read the "Terms of Use Section" of the BioltechnologyEvents.com website prior to any and all uses of the content contained on the pages of the Biotechnologyevents.com website. http://www.biotechnologyevents.com/node/29
.
Disclaimer: Trading Securities is Risky. A trader is subject to this risk and can lose money. Please read the "Terms of Use Section" of the BioltechnologyEvents.com website prior to any and all uses of the content contained on the pages of the Biotechnologyevents.com website. http://www.biotechnologyevents.com/node/29
.
Subscribe to our Newsletter to receive alerts regarding updates and new additions.
.
1) Achillion Pharmaceuticals, Inc. (ACHN) - http://www.biotechnologyevents.com/node/4541
2) Alexza Pharmaceuticals, Inc. (ALXA) - http://www.biotechnologyevents.com/node/4669
Disclaimer: Please read the "Terms of Use Section" of the BioltechnologyEvents.com website prior to any and all uses of the content contained on the pages of the Biotechnologyevents.com website. http://www.biotechnologyevents.com/node/29
.
_________________________________________________________________________________________________________________________
Alexza Pharmaceuticals, Inc. Trade Strategy
Bullish Strategy: 8/29/12.
Status: Opened
Disclaimer: Trading Securities is Risky. A trader is subject to this risk and can lose money. Please read the "Terms of Use Section" of the BioltechnologyEvents.com website prior to any and all uses of the content contained on the pages of the Biotechnologyevents.com website. http://www.biotechnologyevents.com/node/29
.
BiotechnologyEvents.Com offers a unique and powerful tool that allows the user to mine the biotechnology sector for the all important events that effect the future success of the biotech companies covered.